Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Medicaid preferred drug lists' costs to physicians
Jonathan Ketcham
, Andrew J. Epstein
Business, W. P. Carey School of (WPC)
Marketing
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Medicaid preferred drug lists' costs to physicians'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Drug Costs
69%
Medicaid
63%
Physicians
36%
Costs and Cost Analysis
29%
Pharmaceutical Preparations
23%
Medicare Part D
22%
Confidence Intervals
14%
Prescriptions
12%
Cardiologists
10%
Primary Care Physicians
10%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
9%
Antihypertensive Agents
8%
Centers for Medicare and Medicaid Services (U.S.)
6%
Pharmacy
4%
Compliance
4%
Cost-Benefit Analysis
4%
Health
2%
Therapeutics
0%
Social Sciences
drug list
100%
physician
43%
costs
32%
confidence
15%
medication
10%
simulation
3%
health
1%
experience
1%